122 related articles for article (PubMed ID: 31593797)
1. Thresholds for clinical importance were defined for the European Organisation for Research and Treatment of Cancer Computer Adaptive Testing Core-an adaptive measure of core quality of life domains in oncology clinical practice and research.
Giesinger JM; Loth FLC; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; van Leeuwen M; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
J Clin Epidemiol; 2020 Jan; 117():117-125. PubMed ID: 31593797
[TBL] [Abstract][Full Text] [Related]
2. Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research.
Giesinger JM; Loth FLC; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; van Leeuwen M; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
J Clin Epidemiol; 2020 Feb; 118():1-8. PubMed ID: 31639445
[TBL] [Abstract][Full Text] [Related]
3. The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire.
Petersen MA; Aaronson NK; Arraras JI; Chie WC; Conroy T; Costantini A; Dirven L; Fayers P; Gamper EM; Giesinger JM; Habets EJJ; Hammerlid E; Helbostad J; Hjermstad MJ; Holzner B; Johnson C; Kemmler G; King MT; Kaasa S; Loge JH; Reijneveld JC; Singer S; Taphoorn MJB; Thamsborg LH; Tomaszewski KA; Velikova G; Verdonck-de Leeuw IM; Young T; Groenvold M;
Eur J Cancer; 2018 Sep; 100():8-16. PubMed ID: 29936066
[TBL] [Abstract][Full Text] [Related]
4. International validation of the EORTC CAT Core: a new adaptive instrument for measuring core quality of life domains in cancer.
Petersen MA; Aaronson NK; Conroy T; Costantini A; Giesinger JM; Hammerlid E; Holzner B; Johnson CD; Kieffer JM; van Leeuwen M; Nolte S; Ramage JK; Tomaszewski KA; Waldmann A; Young T; Zotti P; Groenvold M;
Qual Life Res; 2020 May; 29(5):1405-1417. PubMed ID: 31955374
[TBL] [Abstract][Full Text] [Related]
5. Establishing the European Norm for the health-related quality of life domains of the computer-adaptive test EORTC CAT Core.
Liegl G; Petersen MA; Groenvold M; Aaronson NK; Costantini A; Fayers PM; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M; Nolte S;
Eur J Cancer; 2019 Jan; 107():133-141. PubMed ID: 30576969
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment.
Pilz MJ; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; Holzner B; van Leeuwen M; Loth FLC; Petersen MA; Ramage J; Tomaszewski KA; Young T; Giesinger JM
J Palliat Med; 2021 Mar; 24(3):397-404. PubMed ID: 32835601
[No Abstract] [Full Text] [Related]
7. Identifying health-related quality of life cut-off scores that indicate the need for supportive care in young adults with cancer.
Lidington E; Giesinger JM; Janssen SHM; Tang S; Beardsworth S; Darlington AS; Starling N; Szucs Z; Gonzalez M; Sharma A; Sirohi B; van der Graaf WTA; Husson O
Qual Life Res; 2022 Sep; 31(9):2717-2727. PubMed ID: 35476170
[TBL] [Abstract][Full Text] [Related]
8. A cross-cultural convergent parallel mixed methods study of what makes a cancer-related symptom or functional health problem clinically important.
Giesinger JM; Aaronson NK; Arraras JI; Efficace F; Groenvold M; Kieffer JM; Loth FL; Petersen MA; Ramage J; Tomaszewski KA; Young T; Holzner B;
Psychooncology; 2018 Feb; 27(2):548-555. PubMed ID: 28857424
[TBL] [Abstract][Full Text] [Related]
9. Brazilian Validation of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group (QLG) Computerised Adaptive Tests (CAT) Core.
Marta GN; de Souza TYT; Silva ARNSE; Pereira APA; Ferreira Neto DR; Asso RN; Degrande FAM; Nader-Marta G; da Silva MF; Gadia R; Hanna SA; Holzner B; Saad ED; Petersen MA
Curr Oncol; 2021 Aug; 28(5):3373-3383. PubMed ID: 34590597
[TBL] [Abstract][Full Text] [Related]
10. Thresholds for clinical importance for four key domains of the EORTC QLQ-C30: physical functioning, emotional functioning, fatigue and pain.
Giesinger JM; Kuijpers W; Young T; Tomaszewski KA; Friend E; Zabernigg A; Holzner B; Aaronson NK
Health Qual Life Outcomes; 2016 Jun; 14():87. PubMed ID: 27267486
[TBL] [Abstract][Full Text] [Related]
11. Development of standard computerised adaptive test (CAT) settings for the EORTC CAT Core.
Petersen MA; Vachon H; Giesinger JM; Groenvold M;
Qual Life Res; 2024 Apr; 33(4):951-961. PubMed ID: 38231438
[TBL] [Abstract][Full Text] [Related]
12. Identifying cutoff scores for the EORTC QLQ-C30 and the head and neck cancer-specific module EORTC QLQ-H&N35 representing unmet supportive care needs in patients with head and neck cancer.
Jansen F; Snyder CF; Leemans CR; Verdonck-de Leeuw IM
Head Neck; 2016 Apr; 38 Suppl 1():E1493-500. PubMed ID: 27111696
[TBL] [Abstract][Full Text] [Related]
13. Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer.
Rothmund M; Pilz MJ; Schlosser L; Arraras JI; Groenvold M; Holzner B; van Leeuwen M; Petersen MA; Schmidt H; Young T; Rose M; Cella D; Giesinger JM;
J Clin Epidemiol; 2024 Jan; 165():111203. PubMed ID: 37918641
[TBL] [Abstract][Full Text] [Related]
14. Development of an item bank for the EORTC Role Functioning Computer Adaptive Test (EORTC RF-CAT).
Gamper EM; Petersen MA; Aaronson N; Costantini A; Giesinger JM; Holzner B; Kemmler G; Oberguggenberger A; Singer S; Young T; Groenvold M;
Health Qual Life Outcomes; 2016 May; 14():72. PubMed ID: 27150974
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
[TBL] [Abstract][Full Text] [Related]
16. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
[TBL] [Abstract][Full Text] [Related]
17. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
[TBL] [Abstract][Full Text] [Related]
18. Do patients consider computer-adaptive measures more appropriate than static questionnaires?
Gamper EM; Martini C; Petersen MA; Virgolini I; Holzner B; Giesinger JM
J Patient Rep Outcomes; 2019 Jan; 3(1):7. PubMed ID: 30694417
[TBL] [Abstract][Full Text] [Related]
19. Development and psychometric evaluation of item banks for memory and attention - supplements to the EORTC CAT Core instrument.
Rogge AA; Petersen MA; Aaronson NK; Conroy T; Dirven L; Fischer F; Habets E; Reijneveld JC; Rose M; Sleurs C; Taphoorn M; Tomaszewski KA; Vachon H; Young T; Groenvold M;
Health Qual Life Outcomes; 2023 Nov; 21(1):124. PubMed ID: 37968682
[TBL] [Abstract][Full Text] [Related]
20. General population normative data for the EORTC QLQ-C30 health-related quality of life questionnaire based on 15,386 persons across 13 European countries, Canada and the Unites States.
Nolte S; Liegl G; Petersen MA; Aaronson NK; Costantini A; Fayers PM; Groenvold M; Holzner B; Johnson CD; Kemmler G; Tomaszewski KA; Waldmann A; Young TE; Rose M;
Eur J Cancer; 2019 Jan; 107():153-163. PubMed ID: 30576971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
